Predict your next investment

Asset/Investment Management

See what CB Insights has to offer

Investments

1

About Capillary

Capillary is an investment firm that provides services to security or commodity holders.

Capillary Headquarter Location

Finland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Capillary

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Capillary in 1 CB Insights research brief, most recently on Oct 28, 2020.

Latest Capillary News

Next-Generation Nano-, Capillary- and Micro-Flow LC Systems Enhance Productivity and Performance

Sep 9, 2021

Next-Generation Nano-, Capillary- and Micro-Flow LC Systems Enhance Productivity and Performance Principal investigators, laboratories, and proteomics researchers in academia, biopharma and contract research organizations can now benefit from an all-in-one nano-, capillary- and micro-flow liquid chromatography (LC) system. Designed for high sensitivity LC-mass spectrometry (LC-MS) applications, technical capabilities and seamless integration with Thermo Scientific PepMap Neo Columns and Thermo Scientific mass-spectrometry portfolio, the new  Thermo Scientific Vanquish Neo UHPLC System  and  Thermo Scientific PepMap Neo Columns  help users overcome limitations of existing low-flow LC instruments. "Low-flow LC users are limited by technical capacity and a high level of expertise required for system operation," said Kent Davidson, vice president and general manager, high performance chromatography solutions, Thermo Fisher Scientific. "The Vanquish Neo UHPLC System and PepMap Neo Columns allow for long-term operation at maximum performance levels without compromise. Enhanced ease-of-use and increased versatility enable users to push science forward." Professor Bernhard Kuster, Technical University Munich, said, "The Vanquish Neo UHPLC System will transform how scientists perform proteomics studies by providing the long-term robustness and flow-range versatility required for deep and fast LC-MS profiling of thousands of proteomes, while coupled with PepMap Columns and high-resolution accurate mass (HRAM) systems." The new Thermo Scientific Vanquish Neo UHPLC System and Thermo Scientific PepMap Neo Columns deliver application flexibility and robust analytical performance at flow rates from 1 nL/min to 100 µL/min up to 1500 bar. Novice and expert LC-MS users will enjoy accelerated productivity, reduced method overhead time, and long-term operation essential for 24/7 large sample cohort analysis. Users of the Vanquish Neo UHPLC System and PepMap Neo Columns benefit from:  Excellent separation performance, column-to-column reproducibility, and simple operation. Seamless integration with the comprehensive portfolio of Thermo Scientific mass spectrometers. Enhanced quantitation through high-injection volume linearity, precision and accuracy. Negligible system carryover with automated wash routines. System monitoring and control with automated procedures and guided maintenance routines through the Thermo Scientific Vanquish User Interface. For more information on the Thermo Scientific Vanquish Neo UHPLC System, please visit:  www.thermofisher.com/vanquishneo . For more information on the Thermo Scientific PepMap Neo Columns, please visit  http://www.thermofisher.com/lowflowHPLCcolumns . About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit  www.thermofisher.com . Editor Details

Capillary Investments

1 Investments

Capillary has made 1 investments. Their latest investment was in Process Genius as part of their Unattributed on January 1, 2016.

CBI Logo

Capillary Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/27/2016

Unattributed

Process Genius

$0.45M

Yes

1

Date

1/27/2016

Round

Unattributed

Company

Process Genius

Amount

$0.45M

New?

Yes

Co-Investors

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.